24/7 Wall St.42d agoneutral
Eli Lilly Just Won FDA Approval for a Once Weekly Insulin and the Stock Is Knocking on $1,200Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
106last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.43d agobullish
Eli Lilly (LLY) Wins Two FDA Approvals And A $3.35 Billion Drug AllianceThe Wall Street Journal47d agoneutral
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in TrialThe Wall Street Journal48d agoneutral
Pharmaceutical Companies Push Trump Administration to Protect China DealsBenzinga Private Markets48d agoneutral
The $15.6B Smart Ring Bet: Oura Takes On Wall Street With IPOBloomberg48d agobearishVIDEO
Accenture Up on Partnership with Anthropic; Novo Nordisk Falls on Turnaround | Stock MoversThe Wall Street Journal48d agoneutral
Wegovy Maker Novo Looks to New Drugs to Combat Lilly, but Investors Are UnconvincedReuters53d agoneutral
Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugsThe Wall Street Journal55d agoneutral
One State’s Battle to Stop People From Taking Unapproved Weight-Loss DrugsGuruFocus.com58d agobearish
Novo Nordisk Stock Plunges on Morgan Stanley Downgrade Warns of Semaglutide Patent CliffThe Wall Street Journal61d agoneutral
Amgen Stock Poised for Worst Day in More Than Two DecadesMotley Fool62d agoneutral
Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?